Allena Pharmaceuticals is developing and commercializing non-systemic protein therapeutics to treat metabolic and orphan diseases, with a particular focus on nephrologic and urologic conditions. Allena was founded in 2011 with $15 million in Series A venture capital financing led by top-tier venture investors Bessemer Venture Partners, Frazier Healthcare and Third Rock Ventures.Based in Newton, Mass., […]![]()
